Camp4 Therapeutics CSO Daniel Tardiff disposes of 1,738 common shares worth $8,272.88
Reuters2026/08/20 00:46- Camp4 Therapeutics Chief Scientific Officer Daniel Tardiff sold 1,738 common shares on Aug. 19, 2026 at USD 4.76.
- Direct holdings fell to 0 shares following the transaction.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound edges lower as USD steadies above three-month low; downside seems limited
TRUMP reached a peak of 1.86 USDT this morning, up 25.07% in 24 hours.
After the earnings fiasco, OpenAI CFO urgently reassures staff at an all-hands meeting: Q3 ARR has increased by 35%, and the company may go public in 2027 or even earlier.
Facing dual pressures of only 18% revenue growth in Q2 and successive executive departures, OpenAI’s CFO disclosed in an all-hands meeting the latest Q3 data: overall ARR has grown by 35% to date, while enterprise ARR has increased by 50%. She also stated clearly that the company “will go public by 2027 or earlier.” Additionally, she assured employees not to worry about Anthropic possibly going public first, saying, “We are running our own race.”
Redwood Capital Management disposes of Office Properties Income Trust shares worth $3.74 million
Crypto prices
More
